Market closed

Olema Pharmaceuticals/$OLMA

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Olema Pharmaceuticals

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Ticker

$OLMA
Trading on

Industry

Biotechnology

Employees

85
Website

OLMA Metrics

BasicAdvanced
$660M
Market cap
-
P/E ratio
-$2.07
EPS
2.07
Beta
-
Dividend rate
$660M
2.07
$17.23
$8.51
361K
9.127
9.042
0.378
0.378
-35.47%
-56.40%
2.91
2.91
-6.614
-14.29%
0.64%

What the Analysts think about OLMA

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Olema Pharmaceuticals stock.

OLMA Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

OLMA Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $OLMA

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Olema Pharmaceuticals stock?

Olema Pharmaceuticals (OLMA) has a market cap of $660M as of November 13, 2024.

What is the P/E ratio for Olema Pharmaceuticals stock?

The price to earnings (P/E) ratio for Olema Pharmaceuticals (OLMA) stock is 0 as of November 13, 2024.

Does Olema Pharmaceuticals stock pay dividends?

No, Olema Pharmaceuticals (OLMA) stock does not pay dividends to its shareholders as of November 13, 2024.

When is the next Olema Pharmaceuticals dividend payment date?

Olema Pharmaceuticals (OLMA) stock does not pay dividends to its shareholders.

What is the beta indicator for Olema Pharmaceuticals?

Olema Pharmaceuticals (OLMA) has a beta rating of 2.07. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.